These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 37950809)

  • 1. Proteome-wide Mendelian randomization highlights AIF1 and HLA-DQA2 as targets for primary sclerosing cholangitis.
    Chen L; Zhao Y; Li M; Lv G
    Hepatol Int; 2024 Apr; 18(2):517-528. PubMed ID: 37950809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigating the shared genetic architecture between primary sclerosing cholangitis and inflammatory bowel diseases: a Mendelian randomization study.
    Dong X; Gong LL; Hong MZ; Pan JS
    BMC Gastroenterol; 2024 Feb; 24(1):77. PubMed ID: 38373892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic link between primary sclerosing cholangitis and thyroid dysfunction: a bidirectional two-sample Mendelian randomization study.
    Zhang W; Lang R
    Front Immunol; 2023; 14():1276459. PubMed ID: 37928559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leveraging pQTL-based Mendelian randomization to identify new treatment prospects for primary biliary cholangitis and primary sclerosing cholangitis.
    Dai L; Ye Y; Mugaany J; Hu Z; Huang J; Lu C
    Aging (Albany NY); 2024 May; 16(10):9228-9250. PubMed ID: 38809509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary sclerosing cholangitis causally affects kidney function decline: A Mendelian randomization study.
    Cho JM; Koh JH; Kim SG; Lee S; Kim Y; Cho S; Kim K; Kim YC; Han SS; Lee H; Lee JP; Joo KW; Lim CS; Kim YS; Kim DK; Park S
    J Gastroenterol Hepatol; 2024 Jan; 39(1):185-192. PubMed ID: 37726875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Causal relationship between primary sclerosing cholangitis and systemic lupus erythematosus: a bidirectional Mendelian randomization study.
    Pan Z; Zhang W
    Eur J Med Res; 2024 Jun; 29(1):351. PubMed ID: 38943194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic association and causal relationship between multiple modifiable risk factors and autoimmune liver disease: a two-sample mendelian randomization study.
    Gao W; Peng C; Wang Z; Li Y; Liu M
    J Transl Med; 2024 May; 22(1):425. PubMed ID: 38704596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetically predicted gut microbiota mediate the association between plasma lipidomics and primary sclerosing cholangitis.
    Zhou J; Zhu D; Xu Y; Chen C; Wang K
    BMC Gastroenterol; 2024 May; 24(1):158. PubMed ID: 38720308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Causality of immune cells on primary sclerosing cholangitis: a bidirectional two-sample Mendelian randomization study.
    Wu P; Xie S; Cai Y; Liu H; Lv Y; Yang Y; He Y; Yin B; Lan T; Wu H
    Front Immunol; 2024; 15():1395513. PubMed ID: 39011035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A bidirectional two-sample Mendelian randomization using the gut microbiota to reveal potential therapeutic targets for primary sclerosing cholangitis.
    Liang X; Wang Z; Shu Q; Huang X; Wang J; Wu J; Liu N; Xie N
    Eur J Gastroenterol Hepatol; 2024 Feb; 36(2):147-154. PubMed ID: 38131422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic targets for inflammatory bowel disease: proteome-wide Mendelian randomization and colocalization analyses.
    Chen J; Xu F; Ruan X; Sun J; Zhang Y; Zhang H; Zhao J; Zheng J; Larsson SC; Wang X; Li X; Yuan S
    EBioMedicine; 2023 Mar; 89():104494. PubMed ID: 36857861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Causal effects of gut microbiome on autoimmune liver disease: a two-sample Mendelian randomization study.
    Fu Y; Li J; Zhu Y; Chen C; Liu J; Gu S; Zheng Y; Li Y
    BMC Med Genomics; 2023 Oct; 16(1):232. PubMed ID: 37789337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between gut microbiota and autoimmune cholestatic liver disease, a Mendelian randomization study.
    Cui Y; Guo Y; Kong Y; Zhang G
    Front Microbiol; 2024; 15():1348027. PubMed ID: 38601930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteome-wide Mendelian randomization identifies therapeutic targets for ankylosing spondylitis.
    Zhao W; Fang P; Lai C; Xu X; Wang Y; Liu H; Jiang H; Liu X; Liu J
    Front Immunol; 2024; 15():1366736. PubMed ID: 38566994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Causal associations between gut microbiota and Cholestatic liver diseases: a Mendelian randomization study.
    Yang J; Ma G; Wang K; Yang H; Jiang S; Fan Q; Zhou X; Guo G; Han Y
    Front Med (Lausanne); 2024; 11():1342119. PubMed ID: 38327703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel approach to genome-wide association analysis identifies genetic associations with primary biliary cholangitis and primary sclerosing cholangitis in Polish patients.
    Paziewska A; Habior A; Rogowska A; Zych W; Goryca K; Karczmarski J; Dabrowska M; Ambrozkiewicz F; Walewska-Zielecka B; Krawczyk M; Cichoz-Lach H; Milkiewicz P; Kowalik A; Mucha K; Raczynska J; Musialik J; Boryczka G; Wasilewicz M; Ciecko-Michalska I; Ferenc M; Janiak M; Kanikowska A; Stankiewicz R; Hartleb M; Mach T; Grzymislawski M; Raszeja-Wyszomirska J; Wunsch E; Bobinski T; Mikula M; Ostrowski J
    BMC Med Genomics; 2017 Jan; 10(1):2. PubMed ID: 28056976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How genetic risk contributes to autoimmune liver disease.
    Ellinghaus D
    Semin Immunopathol; 2022 Jul; 44(4):397-410. PubMed ID: 35650446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic link between rheumatoid arthritis and autoimmune liver diseases: A two-sample Mendelian randomization study.
    Fan J; Jiang T; He D
    Semin Arthritis Rheum; 2023 Feb; 58():152142. PubMed ID: 36446255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PTGES2 and RNASET2 identified as novel potential biomarkers and therapeutic targets for basal cell carcinoma: insights from proteome-wide mendelian randomization, colocalization, and MR-PheWAS analyses.
    Han QJ; Zhu YP; Sun J; Ding XY; Wang X; Zhang QZ
    Front Pharmacol; 2024; 15():1418560. PubMed ID: 39035989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel insights into autoimmune liver diseases provided by genome-wide association studies.
    Mells GF; Kaser A; Karlsen TH
    J Autoimmun; 2013 Oct; 46():41-54. PubMed ID: 23931959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.